Current Report Filing (8-k)
October 30 2019 - 7:53AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event
reported):
October 30, 2019
____________________________
ChineseInvestors.com, Inc.
(Exact name of registrant as specified
in its charter)
____________________________
Indiana
|
000-54207
|
35-2089868
|
(State of Organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification Number)
|
|
|
|
227 W. Valley Blvd. #208A, San Gabriel, CA
|
|
91776
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(626) 589-2468
(Registrant’s telephone number, including
area code)
Check appropriate box below if the Form 8-K filing is intended
to simultaneously satisfying the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
☐ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title
of each class
|
Trading
Symbol(s)
|
Name
of each exchange on which registered
|
N/A
|
N/A
|
N/A
|
☐ Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
☐ If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 8.01 Other Events
The Company on October 30, 2019 issued a press release in which
it announced that its subsidiary CBD Biotech, Inc., an exempted company with limited liability incorporated in the Cayman Islands
(“CBD Biotech) will attend the "2019 China Industrial Cannabis Investment Seminar" on October 31, 2019 in Shanghai,
China and the "2019 China Industrial Cannabis CBD Industry International Conference" on November 23-24, 2019, in Haerbing,
China.
Item 9.01 Financial Statements and Exhibits
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
Date: October 30, 2019
ChineseInvestors.com, Inc.
By: /s/ Wei Wang
Name: Wei Wang
Title: Chief Executive Officer